An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype
References (18)
The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity
Prog. Neurobiol.
(1993)- et al.
Nicotinic receptors that bind α-bungarotoxin on neurons raise intracellular free Ca2+
Neuron
(1992) - et al.
Neuronal acetylcholine receptors that bind α-bungarotoxin with high affinity function as ligand gated ion channels
Neuron
(1994) - et al.
Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes
J. Pharmacol. Exp. Ther.
(1993) - et al.
Structure and activity of acetylcholine
Nature
(1970) Nicotine-dependence mechanisms and therapeutic strategies
- et al.
Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine and [125I]alpha-bungarotoxin
J. Neurosci.
(1985) - et al.
Activation of ion channels in the frog end-plate by high concentrations of acetylcholine
J. Physiol.
(1988) - et al.
Characterization of a family of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative (DMAC) is a selective agonist at neuronal nicotinic α7/[125I]α-bungarotoxin receptor subtypes
Mol. Pharmacol.
(1995)
There are more references available in the full text version of this article.
Cited by (255)
Silent agonists for α7 nicotinic acetylcholine receptors
2023, Pharmacological ResearchModulation of preeclampsia by the cholinergic anti-inflammatory pathway: Therapeutic perspectives
2021, Biochemical PharmacologyNicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
2020, NeuropharmacologyThe cholinergic anti-inflammatory pathway: an innovative treatment strategy for respiratory diseases and their comorbidities
2018, Current Opinion in Pharmacology
Copyright © 1996 Published by Elsevier Ireland Ltd.